Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).
about
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKHTargeting angiogenesis-dependent calcified neoplasms using combined polymer therapeuticsPyrophosphate arthropathy in hypophosphatasiaCrystals, joints, and consternation.Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed jointsFamilial chondrocalcinosis in the Chiloe Islands, Chile.Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.Inorganic pyrophosphate pool size and turnover rate in arthritic jointsMeasurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremiaPyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition diseaseExtrusion of pyrophosphate into extracellular media by osteoarthritic cartilage incubates.Bisphosphonates for the treatment of osteoporosis: insights for clinicians.Bisphosphonate-Induced Osteonecrosis of the Maxilla Resembling a Persistent Endodontic Lesion.Safety of long-term bisphosphonate therapy for the management of osteoporosis.Osteogenesis imperfecta: diagnosis and treatment.Considerations regarding adherence of anti-osteoporosis therapy.Factors affecting the solubility of calcium pyrophosphate dihydrate crystalsA review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth.Does Chondrocalcinosis Associate With a Distinct Radiographic Phenotype of Osteoarthritis in Knees and Hips? A Case-Control Study.Formation of calcium pyrophosphate crystals in vitro: implications for calcium pyrophosphate crystal deposition disease (pseudogout).Calcium pyrophosphate deposits in synovial membrane.Morphological study of articular cartilage in pyrophosphate arthropathy. (Chondrocalcinosis articularis or calcium pyrophosphate dihydrate crystal deposition diseases)Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging.Bisphosphonates and osteonecrosis of the jaw: a case report.Destructive pseudo-neuroarthropathy associated with calcium pyrophosphate deposition.Chondrogenesis in the synovial tissue is associated with the onset of pseudogout after total knee arthroplasty.
P2860
Q24561827-1B99D1EB-F4C0-42B6-8092-4C30B078D8E6Q33432776-0C8C4E39-0256-435F-A931-25F651A7EE09Q33552974-DDC11AFE-1939-4C0E-B89C-6D3B7C61039DQ33554224-41D6D549-8317-467A-B0B5-9500B4CEB155Q33563495-8282C7AA-ECD4-4AE2-8005-C82E5F2E9FC3Q33569382-E1F7A259-0E19-4D90-9CF2-483C6F796B19Q33633541-E25E0637-C0F6-474E-8E1B-EC9098DE1CCFQ34480593-378A93B2-16C9-498F-A0B9-A48FB9F49F4FQ34508824-52F864E0-4B61-40EE-860B-296392EA319FQ34578925-9D348FB5-29D1-4CA7-9E75-523F38DB7C4DQ35901765-1AA7C342-B7B2-4404-8BA5-2D5C8D0DF01DQ36443681-6D4C828F-EDBB-4456-BEB0-6E3BB525EB9AQ36516261-9E9E794F-2655-4E84-9EDE-D1BC71B42046Q37866764-189C08AA-ADE1-46CD-9FE9-47161BBAEE96Q38223208-FFD52A70-E8FA-43AF-B713-6FE75CBF5B97Q38294766-24BACE08-8738-4534-8927-6A2E7CE09D5AQ39064326-875B00D7-7D6B-4FC7-9907-E9231B755270Q39895119-26FDBE28-6108-4977-8D4E-FC06CE2854C8Q40681153-F19B0AF5-3B47-4612-808A-371EF16B5A0EQ41116451-EA2C746A-C1A4-40DF-9F9C-ED1579263FCCQ41301495-EAB621A2-939D-47BF-BF40-74A9D98D173FQ41305799-BE429809-EAA5-4029-94DA-8447C38AD0E5Q42498080-B4ECC4AE-8383-4C6D-961E-679D7674BB4FQ43151851-47463D16-FA8D-4A5D-9DF5-473389509723Q48807356-55AC5173-33BC-4A29-AF25-2A2F749DF923Q54078600-4A4B377F-E1D9-4FD1-9394-9227A2F1C926
P2860
Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh
1970年學術文章
@zh-hant
name
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@en
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@nl
type
label
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@en
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@nl
prefLabel
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@en
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@nl
P2093
P1433
P1476
Inorganic pyrophosphate in pla ...... ndrocalcinosis or pseudogout).
@en
P2093
H L Currey
H M Rubinstein
I Boussina
R G Russell
P304
P356
10.1016/S0140-6736(70)92070-2
P407
P577
1970-10-01T00:00:00Z